Serveur d'exploration sur le cobalt au Maghreb

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Radiation therapy for the management of patients with HTLV-1–associated adult T-cell leukemia/lymphoma

Identifieur interne : 000353 ( Main/Exploration ); précédent : 000352; suivant : 000354

Radiation therapy for the management of patients with HTLV-1–associated adult T-cell leukemia/lymphoma

Auteurs : Charles B. Simone [États-Unis] ; John C. Morris [États-Unis] ; Donn M. Stewart [États-Unis] ; Nicole E. Urquhart [Jamaïque] ; John E. Janik [États-Unis] ; Robert J. Kreitman ; Elena Lita ; Kevin Conlon [États-Unis] ; Gilian Wharfe [Jamaïque] ; Thomas A. Waldmann [États-Unis] ; Aradhana Kaushal

Source :

RBID : PMC:3433088

Abstract

Human T-cell leukemia virus type 1–associated adult T-cell leukemia/lymphoma (ATL) typically has survivals measured in months with chemotherapy. One prior published series (1983-1991) assessed local radiotherapy for ATL. Ten consecutive patients with pathologically confirmed ATL treated with radiotherapy were reviewed. Subtypes included acute (n = 7), smoldering (n = 2), and lymphomatous (n = 1). Patients received an average of 2.5 systemic therapy regimens before radiotherapy. Twenty lesions (cutaneous = 10, nodal = 8, extranodal = 2) were treated to a mean of 35.4 Gy/2-3 Gy (range, 12-60 Gy). At 9.0-month mean follow-up (range, 0.1-42.0 months), all lesions symptomatically and radiographically responded, with in-field complete responses in 40.0% (nodal 37.5% vs cutaneous 50.0%; P = .62). No patient experienced in-field progression. Nine patients developed new/progressive out-of-field disease. Median survival was 17.0 months (3-year survival, 30.0%). No Radiation Therapy Oncology Group acute grade ≥ 3 or any late toxicity was noted. This report is the first to use modern radiotherapy techniques and finds effective local control across ATL subtypes. Radiotherapy should be considered for symptomatic local progression of ATL.


Url:
DOI: 10.1182/blood-2012-01-401349
PubMed: 22730536
PubMed Central: 3433088


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Radiation therapy for the management of patients with HTLV-1–associated adult T-cell leukemia/lymphoma</title>
<author>
<name sortKey="Simone, Charles B" sort="Simone, Charles B" uniqKey="Simone C" first="Charles B." last="Simone">Charles B. Simone</name>
<affiliation wicri:level="2">
<nlm:aff id="aff1">Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff2">Radiation Oncology Branch</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Morris, John C" sort="Morris, John C" uniqKey="Morris J" first="John C." last="Morris">John C. Morris</name>
<affiliation wicri:level="2">
<nlm:aff id="aff3">Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<nlm:aff id="aff4">Division of Hematology-Oncology, University of Cincinnati, Cincinnati, OH;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Division of Hematology-Oncology, University of Cincinnati, Cincinnati</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Stewart, Donn M" sort="Stewart, Donn M" uniqKey="Stewart D" first="Donn M." last="Stewart">Donn M. Stewart</name>
<affiliation wicri:level="2">
<nlm:aff id="aff3">Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Urquhart, Nicole E" sort="Urquhart, Nicole E" uniqKey="Urquhart N" first="Nicole E." last="Urquhart">Nicole E. Urquhart</name>
<affiliation wicri:level="1">
<nlm:aff wicri:cut="; and" id="aff5">Department of Pathology, University of the West Indies, Mona, Jamaica</nlm:aff>
<country xml:lang="fr">Jamaïque</country>
<wicri:regionArea>Department of Pathology, University of the West Indies, Mona</wicri:regionArea>
<wicri:noRegion>Mona</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Janik, John E" sort="Janik, John E" uniqKey="Janik J" first="John E." last="Janik">John E. Janik</name>
<affiliation wicri:level="2">
<nlm:aff id="aff3">Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kreitman, Robert J" sort="Kreitman, Robert J" uniqKey="Kreitman R" first="Robert J." last="Kreitman">Robert J. Kreitman</name>
<affiliation>
<nlm:aff wicri:cut=", and" id="aff6">Clinical Immunotherapy Section, Laboratory of Molecular Biology</nlm:aff>
<wicri:noCountry code="subfield">Laboratory of Molecular Biology</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Lita, Elena" sort="Lita, Elena" uniqKey="Lita E" first="Elena" last="Lita">Elena Lita</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff2">Radiation Oncology Branch</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Conlon, Kevin" sort="Conlon, Kevin" uniqKey="Conlon K" first="Kevin" last="Conlon">Kevin Conlon</name>
<affiliation wicri:level="2">
<nlm:aff id="aff7">Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wharfe, Gilian" sort="Wharfe, Gilian" uniqKey="Wharfe G" first="Gilian" last="Wharfe">Gilian Wharfe</name>
<affiliation wicri:level="1">
<nlm:aff wicri:cut="; and" id="aff5">Department of Pathology, University of the West Indies, Mona, Jamaica</nlm:aff>
<country xml:lang="fr">Jamaïque</country>
<wicri:regionArea>Department of Pathology, University of the West Indies, Mona</wicri:regionArea>
<wicri:noRegion>Mona</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Waldmann, Thomas A" sort="Waldmann, Thomas A" uniqKey="Waldmann T" first="Thomas A." last="Waldmann">Thomas A. Waldmann</name>
<affiliation wicri:level="2">
<nlm:aff id="aff3">Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kaushal, Aradhana" sort="Kaushal, Aradhana" uniqKey="Kaushal A" first="Aradhana" last="Kaushal">Aradhana Kaushal</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff2">Radiation Oncology Branch</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">22730536</idno>
<idno type="pmc">3433088</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433088</idno>
<idno type="RBID">PMC:3433088</idno>
<idno type="doi">10.1182/blood-2012-01-401349</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000272</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000272</idno>
<idno type="wicri:Area/Pmc/Curation">000271</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000271</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000232</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000232</idno>
<idno type="wicri:Area/Ncbi/Merge">000216</idno>
<idno type="wicri:Area/Ncbi/Curation">000216</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000216</idno>
<idno type="wicri:doubleKey">0006-4971:2012:Simone C:radiation:therapy:for</idno>
<idno type="wicri:Area/Main/Merge">000355</idno>
<idno type="wicri:Area/Main/Curation">000353</idno>
<idno type="wicri:Area/Main/Exploration">000353</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Radiation therapy for the management of patients with HTLV-1–associated adult T-cell leukemia/lymphoma</title>
<author>
<name sortKey="Simone, Charles B" sort="Simone, Charles B" uniqKey="Simone C" first="Charles B." last="Simone">Charles B. Simone</name>
<affiliation wicri:level="2">
<nlm:aff id="aff1">Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff2">Radiation Oncology Branch</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Morris, John C" sort="Morris, John C" uniqKey="Morris J" first="John C." last="Morris">John C. Morris</name>
<affiliation wicri:level="2">
<nlm:aff id="aff3">Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<nlm:aff id="aff4">Division of Hematology-Oncology, University of Cincinnati, Cincinnati, OH;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Division of Hematology-Oncology, University of Cincinnati, Cincinnati</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Stewart, Donn M" sort="Stewart, Donn M" uniqKey="Stewart D" first="Donn M." last="Stewart">Donn M. Stewart</name>
<affiliation wicri:level="2">
<nlm:aff id="aff3">Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Urquhart, Nicole E" sort="Urquhart, Nicole E" uniqKey="Urquhart N" first="Nicole E." last="Urquhart">Nicole E. Urquhart</name>
<affiliation wicri:level="1">
<nlm:aff wicri:cut="; and" id="aff5">Department of Pathology, University of the West Indies, Mona, Jamaica</nlm:aff>
<country xml:lang="fr">Jamaïque</country>
<wicri:regionArea>Department of Pathology, University of the West Indies, Mona</wicri:regionArea>
<wicri:noRegion>Mona</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Janik, John E" sort="Janik, John E" uniqKey="Janik J" first="John E." last="Janik">John E. Janik</name>
<affiliation wicri:level="2">
<nlm:aff id="aff3">Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kreitman, Robert J" sort="Kreitman, Robert J" uniqKey="Kreitman R" first="Robert J." last="Kreitman">Robert J. Kreitman</name>
<affiliation>
<nlm:aff wicri:cut=", and" id="aff6">Clinical Immunotherapy Section, Laboratory of Molecular Biology</nlm:aff>
<wicri:noCountry code="subfield">Laboratory of Molecular Biology</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Lita, Elena" sort="Lita, Elena" uniqKey="Lita E" first="Elena" last="Lita">Elena Lita</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff2">Radiation Oncology Branch</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Conlon, Kevin" sort="Conlon, Kevin" uniqKey="Conlon K" first="Kevin" last="Conlon">Kevin Conlon</name>
<affiliation wicri:level="2">
<nlm:aff id="aff7">Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wharfe, Gilian" sort="Wharfe, Gilian" uniqKey="Wharfe G" first="Gilian" last="Wharfe">Gilian Wharfe</name>
<affiliation wicri:level="1">
<nlm:aff wicri:cut="; and" id="aff5">Department of Pathology, University of the West Indies, Mona, Jamaica</nlm:aff>
<country xml:lang="fr">Jamaïque</country>
<wicri:regionArea>Department of Pathology, University of the West Indies, Mona</wicri:regionArea>
<wicri:noRegion>Mona</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Waldmann, Thomas A" sort="Waldmann, Thomas A" uniqKey="Waldmann T" first="Thomas A." last="Waldmann">Thomas A. Waldmann</name>
<affiliation wicri:level="2">
<nlm:aff id="aff3">Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kaushal, Aradhana" sort="Kaushal, Aradhana" uniqKey="Kaushal A" first="Aradhana" last="Kaushal">Aradhana Kaushal</name>
<affiliation>
<nlm:aff wicri:cut=" and" id="aff2">Radiation Oncology Branch</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Blood</title>
<idno type="ISSN">0006-4971</idno>
<idno type="eISSN">1528-0020</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Human T-cell leukemia virus type 1–associated adult T-cell leukemia/lymphoma (ATL) typically has survivals measured in months with chemotherapy. One prior published series (1983-1991) assessed local radiotherapy for ATL. Ten consecutive patients with pathologically confirmed ATL treated with radiotherapy were reviewed. Subtypes included acute (n = 7), smoldering (n = 2), and lymphomatous (n = 1). Patients received an average of 2.5 systemic therapy regimens before radiotherapy. Twenty lesions (cutaneous = 10, nodal = 8, extranodal = 2) were treated to a mean of 35.4 Gy/2-3 Gy (range, 12-60 Gy). At 9.0-month mean follow-up (range, 0.1-42.0 months), all lesions symptomatically and radiographically responded, with in-field complete responses in 40.0% (nodal 37.5% vs cutaneous 50.0%;
<italic>P</italic>
= .62). No patient experienced in-field progression. Nine patients developed new/progressive out-of-field disease. Median survival was 17.0 months (3-year survival, 30.0%). No Radiation Therapy Oncology Group acute grade ≥ 3 or any late toxicity was noted. This report is the first to use modern radiotherapy techniques and finds effective local control across ATL subtypes. Radiotherapy should be considered for symptomatic local progression of ATL.</p>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Jamaïque</li>
<li>États-Unis</li>
</country>
<region>
<li>Maryland</li>
<li>Ohio</li>
<li>Pennsylvanie</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Kaushal, Aradhana" sort="Kaushal, Aradhana" uniqKey="Kaushal A" first="Aradhana" last="Kaushal">Aradhana Kaushal</name>
<name sortKey="Kreitman, Robert J" sort="Kreitman, Robert J" uniqKey="Kreitman R" first="Robert J." last="Kreitman">Robert J. Kreitman</name>
<name sortKey="Lita, Elena" sort="Lita, Elena" uniqKey="Lita E" first="Elena" last="Lita">Elena Lita</name>
</noCountry>
<country name="États-Unis">
<region name="Pennsylvanie">
<name sortKey="Simone, Charles B" sort="Simone, Charles B" uniqKey="Simone C" first="Charles B." last="Simone">Charles B. Simone</name>
</region>
<name sortKey="Conlon, Kevin" sort="Conlon, Kevin" uniqKey="Conlon K" first="Kevin" last="Conlon">Kevin Conlon</name>
<name sortKey="Janik, John E" sort="Janik, John E" uniqKey="Janik J" first="John E." last="Janik">John E. Janik</name>
<name sortKey="Morris, John C" sort="Morris, John C" uniqKey="Morris J" first="John C." last="Morris">John C. Morris</name>
<name sortKey="Morris, John C" sort="Morris, John C" uniqKey="Morris J" first="John C." last="Morris">John C. Morris</name>
<name sortKey="Stewart, Donn M" sort="Stewart, Donn M" uniqKey="Stewart D" first="Donn M." last="Stewart">Donn M. Stewart</name>
<name sortKey="Waldmann, Thomas A" sort="Waldmann, Thomas A" uniqKey="Waldmann T" first="Thomas A." last="Waldmann">Thomas A. Waldmann</name>
</country>
<country name="Jamaïque">
<noRegion>
<name sortKey="Urquhart, Nicole E" sort="Urquhart, Nicole E" uniqKey="Urquhart N" first="Nicole E." last="Urquhart">Nicole E. Urquhart</name>
</noRegion>
<name sortKey="Wharfe, Gilian" sort="Wharfe, Gilian" uniqKey="Wharfe G" first="Gilian" last="Wharfe">Gilian Wharfe</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000353 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000353 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Terre
   |area=    CobaltMaghrebV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:3433088
   |texte=   Radiation therapy for the management of patients with HTLV-1–associated adult T-cell leukemia/lymphoma
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:22730536" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CobaltMaghrebV1 

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Tue Nov 14 12:56:51 2017. Site generation: Mon Feb 12 07:59:49 2024